Faeth Therapeutics (4070) Q2 2024 Earnings Report
DE:4070 Q2 2024 EPS Results
- Actual EPS
- -EUR 5.01
- Consensus EPS
- -EUR 5.16
- Beat/Miss
- Beat by +EUR 0.15
- One Year Ago EPS
- -EUR 5.54
DE:4070 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 6, 2024
DE:4070 Upcoming Earnings
Faeth Therapeutics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4070 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -0.69- | -3.24 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | -2.36-2.54 | -3.5 | 27.37% (+0.96) | |
| May 15, 2026 | 2026 (Q1) | -0.55-117.53 | -4.83 | -2334.26% (-112.70) | |
| Mar 30, 2026 | 2025 (Q4) | -4.30-3.39 | -5.54 | 38.87% (+2.15) | |
| Nov 14, 2025 | 2025 (Q3) | -3.67-3.24 | -5.19 | 37.59% (+1.95) | |
| Aug 05, 2025 | 2025 (Q2) | -5.01-3.50 | -5.01 | 30.18% (+1.51) | |
| May 06, 2025 | 2025 (Q1) | -3.99-4.83 | -5.72 | 15.63% (+0.89) | |
| Mar 28, 2025 | 2024 (Q4) | -5.07-5.54 | -5.36 | -3.33% (-0.18) | |
| Nov 14, 2024 | 2024 (Q3) | -5.58-5.19 | -5.01 | -3.57% (-0.18) | |
| Aug 06, 2024 | 2024 (Q2) | -5.16-5.01 | -5.54 | 9.68% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
